The most important financial indicators for the company E&A Pharma Grup S.r.l. - Unique Identification Number 16023:
sales in 2023 was
101.469
euro, registering a net profit of
17.296
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 14.2%, from 89.129 euro in the year 2022, to 101.469 euro in 2023.
The Net Profit increased by 4.442 euro, from 12.892 euro in 2022, to 17.296 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
E&A Pharma Grup S.r.l. - CUI 16023
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
10.818
10.719
0
0
0
0
37.910
25.080
15.122
6.009
Current Assets
111.149
40.703
45.971
28.949
41.271
45.181
30.877
24.909
32.097
52.797
Inventories
60.170
23.654
5.350
0
0
3.930
2.898
-339
1.274
10.987
Receivables
19.928
8.416
2.037
25.016
37.609
40.116
27.414
24.401
30.110
40.763
Cash
31.051
8.634
38.584
3.933
3.662
1.135
566
847
713
1.047
Shareholders Funds
36.692
30.350
28.051
6.911
15.271
40.034
36.533
17.792
30.739
47.942
Social Capital
112
112
111
109
107
105
103
101
101
101
Debts
85.275
21.072
17.920
22.038
26.000
5.147
32.254
32.197
16.479
10.864
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
52.797 euro in 2023 which includes Inventories of
10.987 euro, Receivables of
40.763 euro and cash availability of
1.047 euro.
The company's Equity was valued at
47.942 euro, while total Liabilities amounted to
10.864 euro.
Equity increased by 17.296 euro, from 30.739 euro in 2022, to 47.942 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - E&A Pharma Grup S.r.l.